中文 English
Other
Published in : Feb 25, 2025
Global Metabolomics Market Research Report - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2033)

Version Type

Contact us for more information
Email: market@lookwhole.com
  • 5400USD
  • 4200USD
  • 3880USD
  • 5400USD

Report Summary Catalogue Methodological


Definition and Scope:
Metabolomics is a field of study that involves the comprehensive analysis of small molecules present in biological samples such as cells, tissues, or biofluids. It aims to identify and quantify metabolites to understand the metabolic processes occurring in living organisms. By utilizing advanced analytical techniques such as mass spectrometry and nuclear magnetic resonance spectroscopy, metabolomics enables researchers to gain insights into the biochemical pathways, physiological changes, and disease mechanisms at a molecular level. This information can be crucial for various applications including biomarker discovery, drug development, personalized medicine, and nutritional research.
The market for metabolomics is experiencing significant growth driven by several key factors. One of the primary market trends is the increasing adoption of metabolomics in pharmaceutical and biotechnology industries for drug discovery and development. Metabolomics offers valuable insights into drug metabolism, toxicity, and efficacy, thereby helping to accelerate the drug development process. Additionally, the rising prevalence of chronic diseases such as cancer, diabetes, and cardiovascular disorders is fueling the demand for metabolomics technologies for early disease detection, personalized treatment, and monitoring of therapeutic outcomes. Moreover, advancements in analytical technologies, data processing tools, and bioinformatics are enhancing the capabilities and applications of metabolomics, making it a powerful tool in life sciences research.
The global Metabolomics market size was estimated at USD 2411.54 million in 2024, exhibiting a CAGR of 12.90% during the forecast period.
This report offers a comprehensive analysis of the global Metabolomics market, examining all key dimensions. It provides both a macro-level overview and micro-level market details, including market size, trends, competitive landscape, niche segments, growth drivers, and key challenges.
Report Framework and Key Highlights: Market Dynamics: Identification of major market drivers, restraints, opportunities, and challenges.
Trend Analysis: Examination of ongoing and emerging trends impacting the market.
Competitive Landscape: Detailed profiles and market positioning of major players, including market share, operational status, product offerings, and strategic developments.
Strategic Analysis Tools: SWOT Analysis, Porter’s Five Forces Analysis, PEST Analysis, Value Chain Analysis
Market Segmentation: By type, application, region, and end-user industry.
Forecasting and Growth Projections: In-depth revenue forecasts and CAGR analysis through 2033.
This report equips readers with critical insights to navigate competitive dynamics and develop effective strategies. Whether assessing a new market entry or refining existing strategies, the report serves as a valuable tool for:
Industry players
Investors
Researchers
Consultants
Business strategists
And all stakeholders with an interest or investment in the Metabolomics market.
Global Metabolomics Market: Segmentation Analysis and Strategic Insights
This section of the report provides an in-depth segmentation analysis of the global Metabolomics market. The market is segmented based on region (country), manufacturer, product type, and application. Segmentation enables a more precise understanding of market dynamics and facilitates targeted strategies across product development, marketing, and sales.
By breaking the market into meaningful subsets, stakeholders can better tailor their offerings to the specific needs of each segment—enhancing competitiveness and improving return on investment.
Global Metabolomics Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Companies Profiled
Thermo Fisher
Agilent
Metabolon
Shimadzu Corporation
Bruker
Waters Corporation
Biotree
LECO Corporation
Biocrates Life Sciences AG
Human Metabolome Technologies
Metware
Applied Protein Technology
Creative Proteomics
Diagnostic Solutions Laboratory
Market Segmentation by Type
Metabolomics Instruments
Bioinformatics Tools and Services
Market Segmentation by Application
Academic and Research Institutes
Pharmaceutical and Biotechnology Companies
Contract Research Organizations
Geographic Segmentation North America: United States, Canada, Mexico
Europe: Germany, France, Italy, U.K., Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium, Russia.
Asia-Pacific: China, Japan, South Korea, India, Australia, Indonesia, Malaysia, Philippines, Singapore, Thailand
South America: Brazil, Argentina, Colombia.
Middle East and Africa (MEA): Saudi Arabia, United Arab Emirates, Egypt, Nigeria, South Africa, Rest of MEA
Report Framework and Chapter Summary Chapter 1: Report Scope and Market Definition
This chapter outlines the statistical boundaries and scope of the report. It defines the segmentation standards used throughout the study, including criteria for dividing the market by region, product type, application, and other relevant dimensions. It establishes the foundational definitions and classifications that guide the rest of the analysis.
Chapter 2: Executive Summary
This chapter presents a concise summary of the market’s current status and future outlook across different segments—by geography, product type, and application. It includes key metrics such as market size, growth trends, and development potential for each segment. The chapter offers a high-level overview of the Metabolomics Market, highlighting its evolution over the short, medium, and long term.
Chapter 3: Market Dynamics and Policy Environment
This chapter explores the latest developments in the market, identifying key growth drivers, restraints, challenges, and risks faced by industry participants. It also includes an analysis of the policy and regulatory landscape affecting the market, providing insight into how external factors may shape future performance.
Chapter 4: Competitive Landscape
This chapter provides a detailed assessment of the market's competitive environment. It covers market share, production capacity, output, pricing trends, and strategic developments such as mergers, acquisitions, and expansion plans of leading players. This analysis offers a comprehensive view of the positioning and performance of top competitors.
Chapters 5–10: Regional Market Analysis
These chapters offer in-depth, quantitative evaluations of market size and growth potential across major regions and countries. Each chapter assesses regional consumption patterns, market dynamics, development prospects, and available capacity. The analysis helps readers understand geographical differences and opportunities in global markets.
Chapter 11: Market Segmentation by Product Type
This chapter examines the market based on product type, analyzing the size, growth trends, and potential of each segment. It helps stakeholders identify underexplored or high-potential product categories—often referred to as “blue ocean” opportunities.
Chapter 12: Market Segmentation by Application
This chapter analyzes the market based on application fields, providing insights into the scale and future development of each application segment. It supports readers in identifying high-growth areas across downstream markets.
Chapter 13: Company Profiles
This chapter presents comprehensive profiles of leading companies operating in the market. For each company, it details sales revenue, volume, pricing, gross profit margin, market share, product offerings, and recent strategic developments. This section offers valuable insight into corporate performance and strategy.
Chapter 14: Industry Chain and Value Chain Analysis
This chapter explores the full industry chain, from upstream raw material suppliers to downstream application sectors. It includes a value chain analysis that highlights the interconnections and dependencies across various parts of the ecosystem.
Chapter 15: Key Findings and Conclusions
The final chapter summarizes the main takeaways from the report, presenting the core conclusions, strategic recommendations, and implications for stakeholders. It encapsulates the insights drawn from all previous chapters.
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Metabolomics Market Definition
1.2 Metabolomics Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
2 Executive Summary
2.1 Global Metabolomics Market Size
2.2 Market Segmentation – by Type
2.3 Market Segmentation – by Application
2.4 Market Segmentation – by Geography
3 Key Market Trends, Opportunity, Drivers and Restraints
3.1 Key Takeway
3.2 Market Opportunities & Trends
3.3 Market Drivers
3.4 Market Restraints
3.5 Market Major Factor Assessment
4 Global Metabolomics Market Competitive Landscape
4.1 Global Metabolomics Sales by Manufacturers (2020-2025)
4.2 Global Metabolomics Revenue Market Share by Manufacturers (2020-2025)
4.3 Metabolomics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.4 New Entrant and Capacity Expansion Plans
4.5 Mergers & Acquisitions
5 Global Metabolomics Market by Region
5.1 Global Metabolomics Market Size by Region
5.1.1 Global Metabolomics Market Size by Region
5.1.2 Global Metabolomics Market Size Market Share by Region
5.2 Global Metabolomics Sales by Region
5.2.1 Global Metabolomics Sales by Region
5.2.2 Global Metabolomics Sales Market Share by Region
6 North America Market Overview
6.1 North America Metabolomics Market Size by Country
6.1.1 USA Market Overview
6.1.2 Canada Market Overview
6.1.3 Mexico Market Overview
6.2 North America Metabolomics Market Size by Type
6.3 North America Metabolomics Market Size by Application
6.4 Top Players in North America Metabolomics Market
7 Europe Market Overview
7.1 Europe Metabolomics Market Size by Country
7.1.1 Germany Market Overview
7.1.2 France Market Overview
7.1.3 U.K. Market Overview
7.1.4 Italy Market Overview
7.1.5 Spain Market Overview
7.1.6 Sweden Market Overview
7.1.7 Denmark Market Overview
7.1.8 Netherlands Market Overview
7.1.9 Switzerland Market Overview
7.1.10 Belgium Market Overview
7.1.11 Russia Market Overview
7.2 Europe Metabolomics Market Size by Type
7.3 Europe Metabolomics Market Size by Application
7.4 Top Players in Europe Metabolomics Market
8 Asia-Pacific Market Overview
8.1 Asia-Pacific Metabolomics Market Size by Country
8.1.1 China Market Overview
8.1.2 Japan Market Overview
8.1.3 South Korea Market Overview
8.1.4 India Market Overview
8.1.5 Australia Market Overview
8.1.6 Indonesia Market Overview
8.1.7 Malaysia Market Overview
8.1.8 Philippines Market Overview
8.1.9 Singapore Market Overview
8.1.10 Thailand Market Overview
8.1.11 Rest of APAC Market Overview
8.2 Asia-Pacific Metabolomics Market Size by Type
8.3 Asia-Pacific Metabolomics Market Size by Application
8.4 Top Players in Asia-Pacific Metabolomics Market
9 South America Market Overview
9.1 South America Metabolomics Market Size by Country
9.1.1 Brazil Market Overview
9.1.2 Argentina Market Overview
9.1.3 Columbia Market Overview
9.2 South America Metabolomics Market Size by Type
9.3 South America Metabolomics Market Size by Application
9.4 Top Players in South America Metabolomics Market
10 Middle East and Africa Market Overview
10.1 Middle East and Africa Metabolomics Market Size by Country
10.1.1 Saudi Arabia Market Overview
10.1.2 UAE Market Overview
10.1.3 Egypt Market Overview
10.1.4 Nigeria Market Overview
10.1.5 South Africa Market Overview
10.2 Middle East and Africa Metabolomics Market Size by Type
10.3 Middle East and Africa Metabolomics Market Size by Application
10.4 Top Players in Middle East and Africa Metabolomics Market
11 Metabolomics Market Segmentation by Type
11.1 Evaluation Matrix of Segment Market Development Potential (Type)
11.2 Global Metabolomics Sales Market Share by Type (2020-2033)
11.3 Global Metabolomics Market Size Market Share by Type (2020-2033)
11.4 Global Metabolomics Price by Type (2020-2033)
12 Metabolomics Market Segmentation by Application
12.1 Evaluation Matrix of Segment Market Development Potential (Application)
12.2 Global Metabolomics Market Sales by Application (2020-2033)
12.3 Global Metabolomics Market Size (M USD) by Application (2020-2033)
12.4 Global Metabolomics Sales Growth Rate by Application (2020-2033)
13 Company Profiles
13.1 Thermo Fisher
13.1.1 Thermo Fisher Company Overview
13.1.2 Thermo Fisher Business Overview
13.1.3 Thermo Fisher Metabolomics Major Product Offerings
13.1.4 Thermo Fisher Metabolomics Sales and Revenue fromMetabolomics (2020-2025)
13.1.5 Key News
13.2 Agilent
13.2.1 Agilent Company Overview
13.2.2 Agilent Business Overview
13.2.3 Agilent Metabolomics Major Product Offerings
13.2.4 Agilent Metabolomics Sales and Revenue fromMetabolomics (2020-2025)
13.2.5 Key News
13.3 Metabolon
13.3.1 Metabolon Company Overview
13.3.2 Metabolon Business Overview
13.3.3 Metabolon Metabolomics Major Product Offerings
13.3.4 Metabolon Metabolomics Sales and Revenue fromMetabolomics (2020-2025)
13.3.5 Key News
13.4 Shimadzu Corporation
13.4.1 Shimadzu Corporation Company Overview
13.4.2 Shimadzu Corporation Business Overview
13.4.3 Shimadzu Corporation Metabolomics Major Product Offerings
13.4.4 Shimadzu Corporation Metabolomics Sales and Revenue fromMetabolomics (2020-2025)
13.4.5 Key News
13.5 Bruker
13.5.1 Bruker Company Overview
13.5.2 Bruker Business Overview
13.5.3 Bruker Metabolomics Major Product Offerings
13.5.4 Bruker Metabolomics Sales and Revenue fromMetabolomics (2020-2025)
13.5.5 Key News
13.6 Waters Corporation
13.6.1 Waters Corporation Company Overview
13.6.2 Waters Corporation Business Overview
13.6.3 Waters Corporation Metabolomics Major Product Offerings
13.6.4 Waters Corporation Metabolomics Sales and Revenue fromMetabolomics (2020-2025)
13.6.5 Key News
13.7 Biotree
13.7.1 Biotree Company Overview
13.7.2 Biotree Business Overview
13.7.3 Biotree Metabolomics Major Product Offerings
13.7.4 Biotree Metabolomics Sales and Revenue fromMetabolomics (2020-2025)
13.7.5 Key News
13.8 LECO Corporation
13.8.1 LECO Corporation Company Overview
13.8.2 LECO Corporation Business Overview
13.8.3 LECO Corporation Metabolomics Major Product Offerings
13.8.4 LECO Corporation Metabolomics Sales and Revenue fromMetabolomics (2020-2025)
13.8.5 Key News
13.9 Biocrates Life Sciences AG
13.9.1 Biocrates Life Sciences AG Company Overview
13.9.2 Biocrates Life Sciences AG Business Overview
13.9.3 Biocrates Life Sciences AG Metabolomics Major Product Offerings
13.9.4 Biocrates Life Sciences AG Metabolomics Sales and Revenue fromMetabolomics (2020-2025)
13.9.5 Key News
13.10 Human Metabolome Technologies
13.10.1 Human Metabolome Technologies Company Overview
13.10.2 Human Metabolome Technologies Business Overview
13.10.3 Human Metabolome Technologies Metabolomics Major Product Offerings
13.10.4 Human Metabolome Technologies Metabolomics Sales and Revenue fromMetabolomics (2020-2025)
13.10.5 Key News
13.11 Metware
13.11.1 Metware Company Overview
13.11.2 Metware Business Overview
13.11.3 Metware Metabolomics Major Product Offerings
13.11.4 Metware Metabolomics Sales and Revenue fromMetabolomics (2020-2025)
13.11.5 Key News
13.12 Applied Protein Technology
13.12.1 Applied Protein Technology Company Overview
13.12.2 Applied Protein Technology Business Overview
13.12.3 Applied Protein Technology Metabolomics Major Product Offerings
13.12.4 Applied Protein Technology Metabolomics Sales and Revenue fromMetabolomics (2020-2025)
13.12.5 Key News
13.13 Creative Proteomics
13.13.1 Creative Proteomics Company Overview
13.13.2 Creative Proteomics Business Overview
13.13.3 Creative Proteomics Metabolomics Major Product Offerings
13.13.4 Creative Proteomics Metabolomics Sales and Revenue fromMetabolomics (2020-2025)
13.13.5 Key News
13.14 Diagnostic Solutions Laboratory
13.14.1 Diagnostic Solutions Laboratory Company Overview
13.14.2 Diagnostic Solutions Laboratory Business Overview
13.14.3 Diagnostic Solutions Laboratory Metabolomics Major Product Offerings
13.14.4 Diagnostic Solutions Laboratory Metabolomics Sales and Revenue fromMetabolomics (2020-2025)
13.14.5 Key News
13.14.6 Key News
14 Key Market Trends, Opportunity, Drivers and Restraints
14.1 Key Takeway
14.2 Market Opportunities & Trends
14.3 Market Drivers
14.4 Market Restraints
14.5 Market Major Factor Assessment
14.6 Porter's Five Forces Analysis of Metabolomics Market
14.7 PEST Analysis of Metabolomics Market
15 Analysis of the Metabolomics Industry Chain
15.1 Overview of the Industry Chain
15.2 Upstream Segment Analysis
15.3 Midstream Segment Analysis
15.3.1 Manufacturing, Processing or Conversion Process Analysis
15.3.2 Key Technology Analysis
15.4 Downstream Segment Analysis
15.4.1 Downstream Customer List and Contact Details
15.4.2 Customer Concerns or Preference Analysis
16 Conclusion
17 Appendix
17.1 Methodology
17.2 Research Process and Data Source
17.3 Disclaimer
17.4 Note
17.5 Examples of Clients
17.6 Disclaimer
Research Methodology
The research methodology employed in this study follows a structured, four-stage process designed to ensure the accuracy, consistency, and relevance of all data and insights presented. The process begins with Information Procurement, wherein data is collected from a wide range of primary and secondary sources. This is followed by Information Analysis, during which the collected data is systematically mapped, discrepancies across sources are examined, and consistency is established through cross-validation.


Subsequently, the Market Formulation phase involves placing verified data points into an appropriate market context to generate meaningful conclusions. This step integrates analyst interpretation and expert heuristics to refine findings and ensure applicability. Finally, all conclusions undergo a rigorous Validation and Publishing process, where each data point is re-evaluated before inclusion in the final deliverable. The methodology emphasizes bidirectional flow and reversibility between key stages to maintain flexibility and reinforce the integrity of the analysis.
Research Process
The market research process follows a structured and iterative methodology designed to ensure accuracy, depth, and reliability. It begins with scope definition and research design, where the research objectives are clearly outlined based on client requirements, emerging market trends, and initial exploratory insights. This phase provides strategic direction for all subsequent stages of the research.
Data collection is then conducted through both secondary and primary research. Secondary research involves analyzing publicly available and paid sources such as company filings, industry journals, and government databases to build foundational knowledge. This is followed by primary research, which includes direct interviews and surveys with key industry stakeholders—such as manufacturers, distributors, and end users—to gather firsthand insights and address data gaps identified earlier. Techniques included CATI (Computer-Assisted Telephonic Interviewing), CAWI (Computer-Assisted Web Interviewing), CAVI (Computer-Assisted Video Interviewing via platforms like Zoom and WebEx), and CASI (Computer-Assisted Self Interviewing via email or LinkedIn).